investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Prospective Study of Serum MIS and Gynecologic Cancer Risk
Joanne F Dorgan
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Collaborator from New York University
New York University
New York, United States
Vittorio Krogh
Cairo University
Giza, Egypt
Istituto Nazionale dei Tumori (IRCCS)
Milan, Italy
Theron Johnson
German Cancer Research Center (HZ)
Heidelberg, Germany
Naomi Allen
University of Oxford
Oxford, United Kingdom
Annika Idahl
Umeå University
Umeå, Sweden
Joanne F Dorgan
University of Maryland, Baltimore
Baltimore, United States
Related projects
Gary Gilliland
Cancer Center Support grant (comprehensive)
Ovary
Daniel W Cramer
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
Ovary
Pathology
Kunle O Odunsi
RPCI-UPCI Ovarian Cancer SPORE
Ovary
Sandra Orsulic
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
Ovary
David Komander
Specificity in the ubiquitin system
Ovary
Tsz-Kwong Man
Harnessing p27 for Prognostication of Pediatric Osteosarcoma
Ovary
Pediatric oncology or childhood cancer
Garnet L. Anderson
Womens Health Initiative Cancer Survivor Cohort
Corpus uteri
Michelle Hildebrandt
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Ovary
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology